Gene Therapy-Induced CAR T Cells for Myeloma Could Alter Treatment Landscape

(MedPage Today) — ORLANDO — A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable residual disease (MRD)-negative responses in the first four patients with relapsed/refractory multiple myeloma…